In the atheromatous plaque stage, SMS2 overexpression significantly upregulates the expression of aortic matrix metalloproteinase-2 (MMP-2), monocyte (MCP-1, tissue factor (TF), and cyclooxygenase-2 (COX-2) biomarkers of aortitis. The gene discussed is MMP2; the disease is aortitis.